Document Detail

Epithelial ovarian cancer treated by platinum or platinum analogue with cyclophosphamide: experience in Ramathibodi Hospital.
MedLine Citation:
PMID:  9470316     Owner:  NLM     Status:  MEDLINE    
This study presented the outcome of 92 EOC patients treated by platinum or platinum analogue with cyclophosphamide from January 1, 1993 to December 31, 1995. There were 77 evaluable patients. The follow-up ranged from 4-42 months (median 14 months). The over all 3-year survival was 64 per cent and the median progression-free interval was 16 months for the whole group. There was no significant difference in survival between patients who received cisplatin and those who received carboplatin (P = 0.093). Patients who underwent optimal debulking surgery had significantly longer progression-free interval (P = 0.001) than those who had sub-optimal surgery. Fifty four per cent of patients with clear cell carcinoma died of the disease. Patients who received cisplatin had a drop out rate while on therapy more often (24% vs 5.3%) than that of carboplatin. Toxicities from chemotherapy were moderate but manageable.
V Linasmita; S Wilailak; S Srisupundit; S Tangtrakul; S Bullangpoti; N Israngura
Related Documents :
19188136 - A randomized, phase ii trial of two dose schedules of carboplatin/paclitaxel/cetuximab ...
1732426 - Treatment of children with progressive or recurrent brain tumors with carboplatin or ip...
18336396 - Can carboplatin replace cisplatin for intraperitoneal use?
8683236 - Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase ii trial.
18458576 - Intravenous immunoglobulin in the treatment of severe methotrexate-induced acral erythema.
16166766 - Future directions in multiple myeloma treatment.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the Medical Association of Thailand = Chotmaihet thangphaet     Volume:  81     ISSN:  0125-2208     ISO Abbreviation:  J Med Assoc Thai     Publication Date:  1998 Jan 
Date Detail:
Created Date:  1998-03-12     Completed Date:  1998-03-12     Revised Date:  2006-04-24    
Medline Journal Info:
Nlm Unique ID:  7507216     Medline TA:  J Med Assoc Thai     Country:  THAILAND    
Other Details:
Languages:  eng     Pagination:  10-6     Citation Subset:  IM    
Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenocarcinoma / drug therapy*,  mortality,  surgery
Antineoplastic Agents / administration & dosage
Antineoplastic Agents, Alkylating / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carboplatin / administration & dosage
Chemotherapy, Adjuvant
Cisplatin / administration & dosage
Cyclophosphamide / administration & dosage
Middle Aged
Neoplasms, Glandular and Epithelial / drug therapy*,  mortality,  surgery
Ovarian Neoplasms / drug therapy*,  mortality,  surgery
Survival Analysis
Reg. No./Substance:
0/Antineoplastic Agents; 0/Antineoplastic Agents, Alkylating; 15663-27-1/Cisplatin; 41575-94-4/Carboplatin; 50-18-0/Cyclophosphamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Short-term evaluation of captopril in patients with chronic left sided valvular regurgitations.
Next Document:  Maintenance ECT in schizophrenia: a pilot study.